C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia
Maria V. Yusenko(University of Münster), Karl‐Heinz Klempnauer(University of Münster), Débora A. Casolari(South Australia Pathology), Carsten Müller‐Tidow(Heidelberg University), Amke Trentmann(University of Münster), Richard J. D’Andrea(South Australia Pathology), Luca Abdel Ghani(University of Münster), Thomas J. Schmidt(University of Münster), Henning D. Mootz(University of Münster), Thomas J. Gonda(University of South Australia), Wolfgang Dörner(University of Münster), Stefan Klempnauer(Ruhr University Bochum), Jan‐Henrik Mikesch(University Hospital Münster), Melanie Horn(Heidelberg University), Marı́a Francisca Arteaga(University of Münster)
Cited by 24
Related Papers
A family of cytokine-inducible inhibitors of signalling
|Nature|1997|2.1k
MYB function in normal and cancer cells
|Nature reviews. Cancer|2008|627
Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia
|Nature Genetics|2011|604